58
Views
20
CrossRef citations to date
0
Altmetric
Original Article

The Warthin-Finkeldey-Type Giant Cell in HIV Infection, What Is It?

Pages 293-303 | Received 24 Apr 1998, Accepted 01 May 1998, Published online: 10 Jul 2009
 

Abstract

A study was conducted to ascertain the origin of the Warthin-Finkeldey-type giant cell that is common to lymphoid tissues of HIV-infected individuals. Light microscopy (LM) and transmission electron microscopy (TEM), in situ hybridization (ISH) (HIV-specific RNA), and immunohistochemistry (HIV p24, 0PD4, CD3, CD45 UCHL, CD21, CD35, S-100, p55 (actin-bundling protein), CD68, HAM56, α-1antitrypsin, α-1 -antichymotrypsin, and lysozyme) studies were performed on hyperplastic tonsil, adenoid, lymph node, and intestinal MALT specimens from HIV+ patients. Warthin-Finkeldey-type giant cells (WFTGC) and follicular dendritic cells (FDC) shared characteristic morphologic (high N; C ratio; crowded, irregular nuclei, thin filaments with dense bodies; desmosomes; and cilia) and immunophenotypic (CD21+ CD35+, S-100+, p55, and vimentin+) features. Also, transitional forms between binucleated FDC and WFTGC were identified by TEM. TEM and ISH revealed evidence of HIV expression by FDC, but not WFTGC. WFTGC in HIV lymphoid specimens displayed identical LM and IHC characteristics. The WFTGC in HIV infection appears to represent a multinucleated form of FDC.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.